Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ARQT
ARQT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARQT News
Baron Health Care Fund Reports Strong Q4 2025 Performance
4d ago
seekingalpha
Arcutis to Present at TD Cowen Health Care Conference in Boston
Feb 27 2026
Yahoo Finance
Arcutis (ARQT) Q4 2025 Earnings Call Transcript
Feb 26 2026
NASDAQ.COM
Arcutis Biotherapeutics Q4 Earnings Exceed Expectations
Feb 25 2026
seekingalpha
Max Homa Shares Journey with Seborrheic Dermatitis
Feb 24 2026
Newsfilter
Arcutis and Take-Two Options Trading Activity Surges
Feb 19 2026
NASDAQ.COM
Tejara Capital Fully Exits Arcutis Biotherapeutics Stake
Feb 06 2026
Fool
Arcutis' ZORYVE Revenue Reaches $244.6M in 2025 YTD, Anticipates $470M for 2026
Jan 06 2026
NASDAQ.COM
Sprott Silver Miners ETF Declines 2.3% with Americas Gold and Vizsla Silver Underperforming
Dec 31 2025
NASDAQ.COM
Suvretta Capital Reduces Arcutis Stake by $35.78 Million
Dec 23 2025
Fool
Suvretta Capital Management Sells Nearly 1.1M ARQT Shares, Reducing Position by $35.78M
Dec 23 2025
NASDAQ.COM
Zacks Industry Forecast for Arcutis, Amicus, and ANI
Dec 18 2025
NASDAQ.COM
5 Biotech Stocks to Keep an Eye On for Possible Growth
Dec 17 2025
NASDAQ.COM
Evaluating Arcutis Biotherapeutics Following a 99% Year-to-Date Increase and Varied Valuation Indicators
Dec 14 2025
Yahoo Finance
This Biotech Stock Might Alleviate Your Portfolio's Struggles
Dec 14 2025
NASDAQ.COM
Reasons to Consider Arcutis Biotherapeutics, Inc. (ARQT) as a Strong Momentum Stock: Is It Time to Buy?
Dec 10 2025
NASDAQ.COM
Show More News
